...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Share transfer RBC

Ac...I realize that. What I'm suggesting is for management to put out a "fair market value" as opposed to "fair value." A "fair market value" would be better digested by CRA more so than "fair value" in an audit.

 

Koo

Share
New Message
Please login to post a reply